Información del artículo
El Texto completo está disponible en PDF
Bibliografía
[1.]
J. Poniachik, R. Quera, A. Lui.
Insuficiencia hepática fulminante.
Rev Med Chile, 130 (2002), pp. 691-698
[2.]
W. Lee.
Acute liver failure.
N Engl J Med, 329 (1993), pp. 1862-1872
[3.]
J.G. O’Grady, S.W. Schalm, R. Williams.
Acute liver failure: redefining the syndromes.
Lancet, 342 (1993), pp. 373-375
[5.]
J.G. O’Grady, G.J. Alexander, K.M. Hayllar, R. Williams.
Early indicators of prognosis in fulminant hepatic failure.
Gastroenterology, 97 (1989), pp. 439-445
[6.]
R. Bañares, M.V. Catalina.
Indications and therapeutic possibilities of albumin dialysis (MARS).
Rev Esp Enferm Dig, 95 (2003), pp. 876-889
[7.]
N. Rolando, F. Harvey, J. Brahm, J. Philpott-Howard, G. Alexander, A. Gimson, et al.
Prospective study of bacterial infection in acute liver failure: an analysis of fifty patients.
Hepatology, 11 (1990), pp. 49-53
[8.]
L.E. Schmidt, L.P. Wang, B.A. Hansen, F.S. Larsen.
Systemic hemodynamic effects of treatment with the molecular adsorbent recirculating system in patients with hyperacute liver failure: a prospective controlled trial.
Liver Transpl, 9 (2003), pp. 290-297
[9.]
A. Parés.
Sistemas artificiales no biológicos de soporte hepático.
Gastroenterol Hepatol, 25 (2002), pp. 43-47
[10.]
S. Mitzner, J. Stange, S. Klammt, P. Peszynski, R. Schmidt.
Albumin dialysis using the molecular recirculating system.
Curr Opin Nephr Hyp, 10 (2001), pp. 777-783
[11.]
S.R. Mitzner, J. Stange, S. Klammt, P. Peszynski, R. Schmidt, G. Noldge-Schomburg.
Extracorporeal detoxification using the molecular adsorbent recirculating system for critically ill patients with liver failure.
J Am Soc Nephrol, 12 (2001), pp. S75-S82
[12.]
U. Heemann, U. Treichel, J. Loock, T. Philipp, G. Gerken, M. Malago, et al.
Albumin dialysis in cirrhosis with superimposed acute liver injury: a prospective, controlled study.
Hepatology, 36 (2002), pp. 949-958
[13.]
D. Kapoor, R. Williams, R. Jalan.
MARS: a new treatment for hepatorenal failure. Molecular adsorbent and recirculating system.
Gastroenterology, 119 (2000), pp. 1799-1800
[14.]
S.R. Mitzner, J. Stange, S. Klammt, T. Risler, C.M. Erley, B.D. Bader, et al.
Improvement of hepatorenal syndrome with extracorporeal albumin dialysis MARS: results of a prospective, randomized, controlled clinical trial.
Liver Transpl, 6 (2000), pp. 277-286
[15.]
R. Jalan, S. Sen, C. Steiner, D. Kapoor, A. Alisa, R. Williams.
Extracorporeal liver support with molecular adsorbents recirculating system in patients with severe acute alcoholic hepatitis.
J Hepatol, 38 (2003), pp. 24-31
[16.]
R. Kellersmann, H.-J. Gassel, C. Bühler, A. Thiede, W. Timmermann.
Application of molecular adsorbent recirculating system in patients with severe liver failure after hepatic resection or transplantation: initial single-centre experiencies.
Liver, 22 (2002), pp. 56-58
[17.]
L.E. Schmidt, V.R. Sorensen, L.B. Svendsen, B.A. Hansen, F.S. Larsen.
Hemodynamic changes during a single treatment with the molecular adsorbent recirculating system in patients with acuteon-chronic liver failure.
Liver Transpl, 7 (2001), pp. 1034-1039
[18.]
C. Steiner, S. Mitzner.
Experiences with MARS liver support therapy in liver failure: analysis of 176 patients of the International MARS Registry.
Liver, 22 (2002), pp. 20-25
[19.]
G. Novelli, M. Rossi, R. Pretagostini, L. Poli, L. Novelli, P. Berlococ, et al.
MARS (Molecular Adsorbent Recirculating System): experience in 34 cases of acute liver failure.
Liver, 22 (2002), pp. 43-47
[20.]
M. Felldin, S. Friman, M. Olausson, L. Backman, M. Castedal, B. Larsson, et al.
Liver dialysis using MARS in acute hepatic failure. Promising results in a pilot setting.
Lakartidningen, 100 (2003), pp. 3836-3838
[21.]
M. Felldin, S. Friman, L. Backman, A. Siewert-Delle, B.A. Henricksson, B. Larsson, et al.
Treatment with the MARS in patients with acute liver failure.
Transplant Proc, 35 (2003), pp. 822-823
[22.]
L.L. Kjaergard, J. Liu, B. Als-Nielsen, C. Gluud.
Artificial and bioartificial support systems for acute and acute-onchronic liver failure: a systematic review.
JAMA, 289 (2003), pp. 217-222
[23.]
J. Liu, L. Gluud, B. Als-Nielsen, C. Gluud.
Artificial and bioartificial support systems for liver failure.
Cochrane Database Syst Rev, 1 (2004),
[24.]
H. Isoniemi.
Current indications for albumin dyalisis: acute hepatic failure.
4th International Symposium on albumin dyalisis in liver disease, pp. 21-22
[25.]
S. Sen, M. Felldin, C. Steiner, B. Larsson, G. Gillett, M. Olausson.
Albumin dialysis and Molecular Adsorbents Recirculating (MARS) for acute Wilson’s disease.
Liver Transpl, 8 (2002), pp. 962-967
Copyright © 2005. Elsevier España S.L.. Todos los derechos reservados
